MCID: IMM005
MIFTS: 20

Immature Teratoma of Ovary malady

Categories: Reproductive diseases, Rare diseases, Cancer diseases

Aliases & Classifications for Immature Teratoma of Ovary

Aliases & Descriptions for Immature Teratoma of Ovary:

Name: Immature Teratoma of Ovary 12 56 14 69
Malignant Teratoma of Ovary 12 56
Ovarian Malignant Teratoma 56
Ovarian Immature Teratoma 56

Characteristics:

Orphanet epidemiological data:

56
malignant teratoma of ovary
Age of onset: Adolescent,Adult,Childhood,Infancy;

Classifications:



External Ids:

Disease Ontology 12 DOID:6331
NCIt 47 C8111
SNOMED-CT 64 254871000
Orphanet 56 ORPHA398987
ICD10 via Orphanet 34 C56
UMLS 69 C0346182

Summaries for Immature Teratoma of Ovary

MalaCards based summary : Immature Teratoma of Ovary, also known as malignant teratoma of ovary, is related to childhood immature teratoma of ovary and teratoma. An important gene associated with Immature Teratoma of Ovary is CEACAM5 (Carcinoembryonic Antigen Related Cell Adhesion Molecule 5). The drugs Palivizumab and Ribavirin have been mentioned in the context of this disorder. Affiliated tissues include ovary.

Related Diseases for Immature Teratoma of Ovary

Diseases related to Immature Teratoma of Ovary via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 childhood immature teratoma of ovary 12.2
2 teratoma 10.1
3 choroiditis 9.8
4 gliomatosis peritonei 9.8
5 embryonal carcinoma 9.7

Graphical network of the top 20 diseases related to Immature Teratoma of Ovary:



Diseases related to Immature Teratoma of Ovary

Symptoms & Phenotypes for Immature Teratoma of Ovary

Drugs & Therapeutics for Immature Teratoma of Ovary

Drugs for Immature Teratoma of Ovary (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 80)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Palivizumab Approved, Investigational Phase 3 188039-54-5
2
Ribavirin Approved Phase 3 36791-04-5 37542
3
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
4
Caspofungin Approved Phase 3 179463-17-3, 162808-62-0 468682 2826718
5
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
6
Captopril Approved Phase 3 62571-86-2 44093
7
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
8
Fluconazole Approved Phase 3 86386-73-4 3365
9
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
10
Carboplatin Approved Phase 3,Phase 2 41575-94-4 10339178 498142 38904
11
Cisplatin Approved Phase 3,Phase 2 15663-27-1 84093 441203 2767
12
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
13
Bleomycin Approved Phase 3 11056-06-7 5360373
14
Succinylcholine Approved Phase 3 306-40-1 5314
15 Antibodies Phase 3,Phase 1
16 Antibodies, Monoclonal Phase 3,Phase 1
17 Anti-Infective Agents Phase 3,Phase 2
18 Antimetabolites Phase 3
19 Antiviral Agents Phase 3,Phase 2
20 Immunoglobulins Phase 3,Phase 1
21 Anti-Bacterial Agents Phase 3
22 Antifungal Agents Phase 3
23 Antiparasitic Agents Phase 3
24 Antiprotozoal Agents Phase 3
25 Echinocandins Phase 3
26 Liposomal amphotericin B Phase 3
27 Alkylating Agents Phase 3,Phase 2
28 Angiotensin-Converting Enzyme Inhibitors Phase 3
29 Antihypertensive Agents Phase 3
30 Antineoplastic Agents, Alkylating Phase 3,Phase 2
31 Antirheumatic Agents Phase 3
32 HIV Protease Inhibitors Phase 3
33 Immunosuppressive Agents Phase 3,Phase 1,Phase 2
34
protease inhibitors Phase 3
35 Cytochrome P-450 CYP2C9 Inhibitors Phase 3
36 Cytochrome P-450 CYP3A Inhibitors Phase 3
37 Cytochrome P-450 Enzyme Inhibitors Phase 3
38 Hormone Antagonists Phase 3,Phase 1,Phase 2
39 Hormones Phase 3,Phase 1,Phase 2
40 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 1,Phase 2
41 Hydroxyitraconazole Phase 3
42 Steroid Synthesis Inhibitors Phase 3
43 Antimitotic Agents Phase 3,Phase 2
44 Antineoplastic Agents, Phytogenic Phase 3,Phase 2
45 Etoposide phosphate Phase 3,Phase 2
46 Topoisomerase Inhibitors Phase 3,Phase 2
47 Antibiotics, Antitubercular Phase 3
48 Dermatologic Agents Phase 3
49 Keratolytic Agents Phase 3
50 Neuromuscular Agents Phase 3

Interventional clinical trials:

(show all 19)
id Name Status NCT ID Phase
1 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3
2 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3
3 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3
4 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3
5 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3
6 Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Recruiting NCT03067181 Phase 3
7 Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment Completed NCT00453310 Phase 2
8 Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00002673 Phase 2
9 Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors Completed NCT00470366 Phase 2
10 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2
11 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Completed NCT00004157 Phase 2
12 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
13 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2
14 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer Completed NCT00002931 Phase 2
15 PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCER Recruiting NCT01037790 Phase 2
16 Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer Completed NCT00060372 Phase 1
17 Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors Completed NCT00003107 Phase 1
18 Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation Completed NCT00060021
19 Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer Completed NCT00049465

Search NIH Clinical Center for Immature Teratoma of Ovary

Genetic Tests for Immature Teratoma of Ovary

Anatomical Context for Immature Teratoma of Ovary

MalaCards organs/tissues related to Immature Teratoma of Ovary:

39
Ovary

Publications for Immature Teratoma of Ovary

Articles related to Immature Teratoma of Ovary:

id Title Authors Year
1
Gliomatosis Peritonei Arising in Setting of Immature Teratoma of Ovary: A Case Report and Review of Literature. ( 27298531 )
2016
2
Immature teratoma of ovary--outcome following primary and secondary surgery: study of a single institution cohort. ( 26142911 )
2015
3
Immature teratoma of ovary composed largely of choroid plexus. ( 20683425 )
2010

Variations for Immature Teratoma of Ovary

Expression for Immature Teratoma of Ovary

Search GEO for disease gene expression data for Immature Teratoma of Ovary.

Pathways for Immature Teratoma of Ovary

GO Terms for Immature Teratoma of Ovary

Sources for Immature Teratoma of Ovary

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....